Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
3.910
-0.270 (-6.46%)
At close: Feb 21, 2025, 4:00 PM
4.200
+0.290 (7.42%)
After-hours: Feb 21, 2025, 7:22 PM EST
Telomir Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 116 | 123 | - | - | - |
| Enterprise Value | 115 | 122 | - | - | - |
| Last Close Price | 3.91 | 4.12 | - | - | - |
| PB Ratio | 180.98 | 190.63 | - | - | - |
| P/TBV Ratio | 190.63 | 190.63 | - | - | - |
| Debt / Equity Ratio | 0.15 | 0.15 | 0.18 | -0.62 | -0.86 |
| Quick Ratio | 1.86 | 1.86 | 0.00 | 0.00 | - |
| Current Ratio | 1.94 | 1.94 | 0.33 | 0.05 | - |
| Return on Equity (ROE) | -810.18% | -810.18% | -1045.36% | - | - |
| Return on Assets (ROA) | -250.96% | -250.96% | -102.18% | - | - |
| Return on Capital (ROIC) | -318.60% | -318.60% | -132.78% | - | - |
| Earnings Yield | -14.21% | -13.49% | - | - | - |
| FCF Yield | -4.36% | -4.14% | - | - | - |
| Buyback Yield / Dilution | -8.18% | -8.18% | -1.77% | - | - |
| Total Shareholder Return | -8.18% | -8.18% | -1.77% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.